Sergio Romeo

Via L. Mangiagalli 25
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation.

Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation.

Journal: European journal of medicinal chemistry

Published: February 25, 2025

Neuropeptide Y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy.

Neuropeptide Y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 24, 2025

Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities.

Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities.

Journal: Biomolecules

Published: March 09, 2023

From DC18 to MR07: A Metabolically Stable 4,4'-Oxybisbenzoyl Amide as a Low-Nanomolar Growth Inhibitor of P. falciparum.

From DC18 to MR07: A Metabolically Stable 4,4'-Oxybisbenzoyl Amide as a Low-Nanomolar Growth Inhibitor of P. falciparum.

Journal: ChemMedChem

Published: July 01, 2022

Perfluorinated Probes for Noncovalent Protein Recognition and Isolation.

Perfluorinated Probes for Noncovalent Protein Recognition and Isolation.

Journal: Bioconjugate chemistry

Published: January 14, 2020

Discovery and Pharmacophore Mapping of a Low-Nanomolar Inhibitor of P. falciparum Growth.

Discovery and Pharmacophore Mapping of a Low-Nanomolar Inhibitor of P. falciparum Growth.

Journal: ChemMedChem

Published: September 12, 2019

Synthesis and antimycobacterial activity of (+)-usnic acid conjugates.

Synthesis and antimycobacterial activity of (+)-usnic acid conjugates.

Journal: Archiv der Pharmazie

Published: June 07, 2018

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

Journal: Molecules (Basel, Switzerland)

Published: October 24, 2017

Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.

Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.

Journal: Bioconjugate chemistry

Published: November 05, 2016

"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.

"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.

Journal: Pharmacological research

Published: March 25, 2016

Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.

Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.

Journal: PloS one

Published: January 05, 2016

Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.

Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.

Journal: PloS one

Published: April 22, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026